Literature DB >> 8013385

Interleukin-1 regulates corticosterone secretion from the rat adrenal gland through a catecholamine-dependent and prostaglandin E2-independent mechanism.

N A O'Connell1, A Kumar, K Chatzipanteli, A Mohan, R K Agarwal, C Head, S R Bornstein, A B Abou-Samra, A R Gwosdow.   

Abstract

Studies from this and other laboratories have shown that interleukin-1 alpha (IL-1 alpha) stimulates corticosterone and prostaglandin (PG) release from primary cultures of rat adrenal cells. A previous report from our laboratory (1) indicated involvement of the alpha-adrenergic system in IL-1 alpha-stimulated corticosterone secretion from primary cultures of rat adrenal cells. The present experiments were conducted to determine the role of catecholamines and eicosanoids in IL-1-stimulated corticosterone release from primary rat adrenal cells. Primary adrenal cells were incubated for 24 h at 37 C with IL-1 alpha (10 nM), medium, or the appropriate agonist. After incubation, the supernatant was removed and assayed for epinephrine, prostaglandin E2 (PGE2), and corticosterone concentrations. At this time, untreated adrenal cells were fixed for immunohistochemical staining with a specific antirat tyrosine hydroxylase antibody. The results indicate that the primary adrenal cells contained 3.1 +/- 0.45% tyrosine hydroxylase-positive cells. On the ultrastructural level, the chromaffin cells were found to be in direct cellular contact with cortical cells. IL-1 alpha significantly increased (P < 0.05) epinephrine, PGE2, and corticosterone levels above those in medium-treated controls from primary adrenal cells. In the presence of the alpha-adrenergic antagonist phentolamine (10 microM), IL-1 alpha-stimulated (P < 0.05) corticosterone release was inhibited, whereas IL-1 alpha-induced PGE2 release was not affected. Conversely, the presence of the cyclooxygenase inhibitor indomethacin (10 microM) significantly inhibited IL-1 alpha-induced PGE2 secretion without altering the effect of IL-1 alpha on corticosterone release. Inhibitors of the 5-lipoxygenase system (10 microM CGS 8518) and the lipoxygenase and cytochrome P450 monooxygenase systems (10 microM nordihydroguaiaretic acid) did not effect IL-1 alpha-induced corticosterone or PGE2 release. These observations indicate that IL-1 alpha stimulates corticosterone release through an alpha-adrenergic mechanism that is independent of PGE2 release from primary rat adrenal cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013385     DOI: 10.1210/endo.135.1.8013385

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

1.  Regulation of SFRP-1 expression in the rat dental follicle.

Authors:  Dawen Liu; Shaomian Yao; Gary E Wise
Journal:  Connect Tissue Res       Date:  2012-03-14       Impact factor: 3.417

2.  Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids.

Authors:  Lee Shaashua; Ella Rosenne; Elad Neeman; Liat Sorski; Luba Sominsky; Pini Matzner; Gayle G Page; Shamgar Ben-Eliyahu
Journal:  Psychoneuroendocrinology       Date:  2014-01-07       Impact factor: 4.905

3.  In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.

Authors:  Ella Rosenne; Liat Sorski; Lee Shaashua; Elad Neeman; Pini Matzner; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2013-12-12       Impact factor: 7.217

4.  The rapid release of corticosterone from the adrenal induced by ACTH is mediated by nitric oxide acting by prostaglandin E2.

Authors:  Claudia E Mohn; Javier Fernandez-Solari; Andrea De Laurentiis; Juan Pablo Prestifilippo; Carolina de la Cal; Richard Funk; Stefan R Bornstein; Samuel M McCann; Valeria Rettori
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-18       Impact factor: 11.205

Review 5.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

6.  Expression of interleukin-1 in human pheochromocytoma.

Authors:  S R Bornstein; M Ehrhart-Bornstein; J González-Hernández; S Schröder; W A Scherbaum
Journal:  J Endocrinol Invest       Date:  1996-11       Impact factor: 4.256

7.  In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences.

Authors:  L Shaashua; L Sominsky; B Levi; L Sorski; M Reznick; G G Page; S Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2012-05-29       Impact factor: 7.217

8.  Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies.

Authors:  Włodzimierz Matysiak; Barbara Jodłowska-Jedrych
Journal:  Protoplasma       Date:  2010-08-19       Impact factor: 3.356

9.  Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy.

Authors:  P J Jenkins; S A Sohaib; P J Trainer; T A Lister; G M Besser; R Reznek
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

10.  Salient type 1 interleukin 1 receptor expression in peripheral non-immune cells.

Authors:  Anping Song; Ling Zhu; Gowthami Gorantla; Olimpia Berdysz; Stephanie A Amici; Mireia Guerau-de-Arellano; Kathryn M Madalena; Jessica K Lerch; Xiaoyu Liu; Ning Quan
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.